arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Nautilus Biotechnology, Inc.

NAUT Industrials Biotechnology: Laboratory Analytical Instruments
$2.60
▲ +2.0% Today
as of Oct 22, 16:50 ET
Last 30 days +186.98% Sep 14 → Oct 22
$0.75 $1.27 $1.80 $2.33 $2.86 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$2.75
High
$2.86
Low
$2.54
Volume
$7M
Avg Vol
$1M
Mkt Cap
$249M
P/E (TTM)
—
Beta
—
52w High
$4.31
52w Low
$0.84
Div Yield
—
Shares Out
$127M

Recent Press Releases & News last 60 days · 2 items

Oct 15 · 12:00 PR GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
Sep 11 · 20:33 MT Newswires
Nautilus Biotechnology Files $300 Million Shelf Registration

NAUT earnings at a glance

Nautilus Biotechnology, Inc. (NAUT) is scheduled to report earnings on Monday, October 26, 2026 — in 3 days. Analysts expect earnings per share of -$0.14, compared with -$0.11 in the same quarter last year (-27%). The options market is pricing a move of about ±19.7% after the report, a range of roughly $2.09 to $3.11 from today's $2.60. Over its last 3 reports the stock rose the next day 2 times and fell 1, moving ±4.6% on average; after the most recent report on Oct 27, 2025 it moved +5.9%. That means options currently expect more movement than NAUT has typically delivered. NAUT beat the consensus EPS estimate in 1 of its last 1 reported quarters. Implied volatility is currently 157%. The share price of $2.60 sits in the middle of its 52-week range.

More Industrials stocks · All stocks · Earnings calendar

Overview

52-week range
$0.84
$4.31
51% of range
Avg surprise (last 1)
+7.1%
Avg reaction (last 3)
+4.6%
67% positive
Latest IV / EM
157%
EM ±19.7% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.65$-0.39$-0.13$0.13$0.39 Actual $-0.11Actual $-0.12Actual $-0.13Actual $-0.13Actual $-0.15Actual $-0.14Actual $-0.13Actual $-0.13Est $-0.14Actual $-0.12Actual $-0.11Actual $-0.12Actual $-0.11 SepMarJunSepMarJunSepMar/2025Jun/2025Sep/2025MarJun
Revenue vs Net Income Revenue Net income
$-17M$-12M$-8M$-4M$199,500 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.11 — — — — financials
Tue Mar 31, 2026Mar 2026 $-0.12 — — — — financials
Mon Oct 27, 2025Sep/2025 $-0.11 — — — +5.9% earnings
Thu Jul 31, 2025Jun/2025 $-0.12 — — — 0.0% earnings
Tue Apr 29, 2025Mar/2025 $-0.13 $-0.14 +7.1% — +7.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.13 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.14 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.15 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.13 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.13 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.12 — — — — financials
Fri Sep 30, 2022Sep 2022 $-0.11 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Oct 26, 2026Sep/2026OTHER -$0.14-$0.11 -27.3%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$190,000———$0———
Cost of revenue$15,000———$0———
Gross profit————————
Operating income————————
Net income$-14M$-15M—$-14M$-15M$-17M—$-16M
EPS (diluted)$-0.11$-0.12—$-0.11$-0.12$-0.13—$-0.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$13M$15M$12M$24M$34M$33M$28M$4M
Inventory$600,000$300,000——————
Total current assets$88M$99M$106M$134M$151M$142M$133M$144M
Total assets$164M$178M$191M$201M$213M$228M$243M$260M
Long-term debt————————
Total liabilities$32M$33M$34M$32M$32M$33M$34M$36M
Total equity$131M$144M$157M$169M$181M$194M$209M$223M

Implied volatility — last 90 days

81%2217%4352%6488%8624% Jun 08 — IV 81% · EM ±10.7%Jun 10 — IV 150% · EM ±17.7%Jun 16 — IV 702% · EM ±41.5%Jun 25 — IV 112% · EM ±22.0%Jun 29 — IV 339% · EM ±60.1%Jun 30 — IV 481% · EM ±82.9%Jul 01 — IV 616% · EM ±102.8%Jul 06 — IV 651% · EM ±90.1%Jul 07 — IV 694% · EM ±91.7%Jul 08 — IV 762% · EM ±95.5%Jul 09 — IV 524% · EM ±61.9%Jul 10 — IV 455% · EM ±50.3%Jul 13 — IV 874% · EM ±73.0%Jul 14 — IV 1145% · EM ±82.9%Jul 15 — IV 1419% · EM ±83.8%Jul 16 — IV 2305% · EM ±96.3%Jul 21 — IV 417% · EM ±97.1%Jul 22 — IV 399% · EM ±91.2%Jul 24 — IV 388% · EM ±85.8%Jul 27 — IV 499% · EM ±104.2%Jul 28 — IV 1068% · EM ±218.5%Jul 29 — IV 1584% · EM ±317.3%Jul 30 — IV 1448% · EM ±283.7%Jul 31 — IV 1818% · EM ±348.0%Aug 03 — IV 1425% · EM ±252.5%Aug 04 — IV 2034% · EM ±350.3%Aug 05 — IV 1899% · EM ±317.2%Aug 06 — IV 2198% · EM ±355.5%Aug 07 — IV 2311% · EM ±361.1%Aug 10 — IV 2728% · EM ±377.9%Aug 11 — IV 2763% · EM ±364.8%Aug 12 — IV 2883% · EM ±361.2%Aug 13 — IV 2996% · EM ±353.9%Aug 14 — IV 3247% · EM ±358.7%Aug 17 — IV 4283% · EM ±357.8%Aug 18 — IV 5275% · EM ±381.5%Aug 19 — IV 6104% · EM ±360.5%Aug 20 — IV 8625% · EM ±360.2%Aug 24 — IV 1751% · EM ±365.6%Aug 25 — IV 1858% · EM ±380.1%Aug 26 — IV 1678% · EM ±336.0%Aug 27 — IV 1754% · EM ±343.6%Aug 28 — IV 1887% · EM ±361.2%Aug 31 — IV 1886% · EM ±334.2%Sep 01 — IV 1974% · EM ±340.0%Sep 02 — IV 1961% · EM ±327.5%Sep 03 — IV 2051% · EM ±331.7%Sep 04 — IV 2192% · EM ±342.6%Sep 07 — IV 2473% · EM ±342.6%Sep 08 — IV 2774% · EM ±366.4%Sep 09 — IV 1531% · EM ±191.8%Sep 10 — IV 2540% · EM ±300.0%Sep 11 — IV 2547% · EM ±281.4%Sep 14 — IV 3922% · EM ±327.6%Sep 15 — IV 4705% · EM ±340.3%Sep 16 — IV 5486% · EM ±324.0%Sep 17 — IV 7516% · EM ±313.9%Sep 21 — IV 1580% · EM ±329.9%Sep 22 — IV 1491% · EM ±305.0%Sep 23 — IV 1565% · EM ±313.5%Sep 24 — IV 1469% · EM ±287.7%Sep 28 — IV 1322% · EM ±234.2%Sep 29 — IV 968% · EM ±166.7%Sep 30 — IV 701% · EM ±117.1%Oct 01 — IV 642% · EM ±103.8%Oct 02 — IV 240% · EM ±37.5%Oct 06 — IV 300% · EM ±39.6%Oct 07 — IV 157% · EM ±19.7%

Sector peers

LAB
Standard BioTools Inc.
$266M $0.64-0.6%
EYPT
EyePoint, Inc.
$286M $0.43+4.4%
QTRX
Quanterix Corporation
$161M $2.84+4.4%
SEER
Seer, Inc.
$122M $1.97-0.5%
RPID
Rapid Micro Biosystems, Inc.
$45M $0.80+3.8%
ATLN
Atlantic International Corp.
$42M $0.90

NAUT earnings FAQ

When is NAUT's next earnings date?

Nautilus Biotechnology, Inc. is expected to report on October 26, 2026.

What is NAUT's expected move for earnings?

Options currently price a move of about ±19.7%, or $0.51 per share either way from $2.60.

How does NAUT stock usually react to earnings?

Across the last 3 reports the average next-day move was ±4.6%, up 2 times and down 1 times.

What EPS are analysts expecting from Nautilus Biotechnology, Inc.?

The consensus estimate is -$0.14 per share, versus -$0.11 a year ago.

What is NAUT's implied volatility?

NAUT's at-the-money implied volatility is about 157% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in